- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 43.54M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.68M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.58M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.75M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.8M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.58M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.59M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.31M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 43.6M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $5.33M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$3.01M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $61.4K |
| Net Income | Q1 2025 · Mar 31, 2024 | $8.08M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$846.96K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.13M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.51M |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.64M |